Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort.

Kim M, Snowden S, Suvitaival T, Ali A, Merkler DJ, Ahmad T, Westwood S, Baird A, Proitsi P, Nevado-Holgado A, Hye A, Bos I, Vos S, Vandenberghe R, Teunissen C, Ten Kate M, Scheltens P, Gabel S, Meersmans K, Blin O, Richardson J, De Roeck E, Sleegers K, Bordet R, Rami L, Kettunen P, Tsolaki M, Verhey F, Sala I, Lléo A, Peyratout G, Tainta M, Johannsen P, Freund-Levi Y, Frölich L, Dobricic V, Engelborghs S, Frisoni GB, Molinuevo JL, Wallin A, Popp J, Martinez-Lage P, Bertram L, Barkhof F, Ashton N, Blennow K, Zetterberg H, Streffer J, Visser PJ, Lovestone S, Legido-Quigley C.

Alzheimers Dement. 2019 Jun;15(6):817-827. doi: 10.1016/j.jalz.2019.03.004. Epub 2019 May 8.

2.

Inflammatory biomarkers in Alzheimer's disease plasma.

Morgan AR, Touchard S, Leckey C, O'Hagan C, Nevado-Holgado AJ; NIMA Consortium, Barkhof F, Bertram L, Blin O, Bos I, Dobricic V, Engelborghs S, Frisoni G, Frölich L, Gabel S, Johannsen P, Kettunen P, Kłoszewska I, Legido-Quigley C, Lleó A, Martinez-Lage P, Mecocci P, Meersmans K, Molinuevo JL, Peyratout G, Popp J, Richardson J, Sala I, Scheltens P, Streffer J, Soininen H, Tainta-Cuezva M, Teunissen C, Tsolaki M, Vandenberghe R, Visser PJ, Vos S, Wahlund LO, Wallin A, Westwood S, Zetterberg H, Lovestone S, Morgan BP; Annex: NIMA–Wellcome Trust Consortium for Neuroimmunology of Mood Disorders and Alzheimer's Disease.

Alzheimers Dement. 2019 Jun;15(6):776-787. doi: 10.1016/j.jalz.2019.03.007. Epub 2019 Apr 30.

3.

Meta-analyses identify differentially expressed micrornas in Parkinson's disease.

Schulz J, Takousis P, Wohlers I, Itua IOG, Dobricic V, Rücker G, Binder H, Middleton L, Ioannidis JPA, Perneczky R, Bertram L, Lill CM.

Ann Neurol. 2019 Jun;85(6):835-851. doi: 10.1002/ana.25490.

PMID:
30990912
4.

A hexanucleotide repeat modifies expressivity of X-linked dystonia parkinsonism.

Westenberger A, Reyes CJ, Saranza G, Dobricic V, Hanssen H, Domingo A, Laabs BH, Schaake S, Pozojevic J, Rakovic A, Grütz K, Begemann K, Walter U, Dressler D, Bauer P, Rolfs A, Münchau A, Kaiser FJ, Ozelius LJ, Jamora RD, Rosales RL, Diesta CCE, Lohmann K, König IR, Brüggemann N, Klein C.

Ann Neurol. 2019 Jun;85(6):812-822. doi: 10.1002/ana.25488. Epub 2019 May 3.

PMID:
30973967
5.

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.

Bos I, Vos S, Verhey F, Scheltens P, Teunissen C, Engelborghs S, Sleegers K, Frisoni G, Blin O, Richardson JC, Bordet R, Tsolaki M, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Lleó A, Johannsen P, Freund-Levi Y, Frölich L, Vandenberghe R, Westwood S, Dobricic V, Barkhof F, Legido-Quigley C, Bertram L, Lovestone S, Streffer J, Andreasson U, Blennow K, Zetterberg H, Visser PJ.

Alzheimers Dement. 2019 May;15(5):644-654. doi: 10.1016/j.jalz.2019.01.004. Epub 2019 Mar 8.

PMID:
30853464
6.

Phenotype of PLP1-related Disorder Caused by Novel Mutation: A Case Report.

Kresojević N, Petrović I, Dobričić V, Tomić A, Branković V, Milić Rašić V, Svetel M, Kostić V.

Mov Disord Clin Pract. 2018 Aug 2;5(5):548-550. doi: 10.1002/mdc3.12644. eCollection 2018 Sep-Oct. No abstract available.

7.

Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.

Djuris J, Milovanovic S, Medarevic D, Dobricic V, Dapčević A, Ibric S.

Int J Pharm. 2019 Jan 10;554:190-200. doi: 10.1016/j.ijpharm.2018.11.015. Epub 2018 Nov 8.

PMID:
30414899
8.

Comparison of the Effect of Bioadhesive Polymers on Stability and Drug Release Kinetics of Biocompatible Hydrogels for Topical Application of Ibuprofen.

Djekic L, Martinović M, Dobričić V, Čalija B, Medarević Đ, Primorac M.

J Pharm Sci. 2019 Mar;108(3):1326-1333. doi: 10.1016/j.xphs.2018.10.054. Epub 2018 Nov 2.

PMID:
30395827
9.

MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study.

Ten Kate M, Redolfi A, Peira E, Bos I, Vos SJ, Vandenberghe R, Gabel S, Schaeverbeke J, Scheltens P, Blin O, Richardson JC, Bordet R, Wallin A, Eckerstrom C, Molinuevo JL, Engelborghs S, Van Broeckhoven C, Martinez-Lage P, Popp J, Tsolaki M, Verhey FRJ, Baird AL, Legido-Quigley C, Bertram L, Dobricic V, Zetterberg H, Lovestone S, Streffer J, Bianchetti S, Novak GP, Revillard J, Gordon MF, Xie Z, Wottschel V, Frisoni G, Visser PJ, Barkhof F.

Alzheimers Res Ther. 2018 Sep 27;10(1):100. doi: 10.1186/s13195-018-0428-1.

10.

Assessing the potential of solid dispersions to improve dissolution rate and bioavailability of valsartan: In vitro-in silico approach.

Medarević D, Cvijić S, Dobričić V, Mitrić M, Djuriš J, Ibrić S.

Eur J Pharm Sci. 2018 Nov 1;124:188-198. doi: 10.1016/j.ejps.2018.08.026. Epub 2018 Aug 23.

PMID:
30144529
11.

Field synopsis and systematic meta-analyses of genetic association studies in isolated dystonia.

Ohlei O, Dobricic V, Lohmann K, Klein C, Lill CM, Bertram L.

Parkinsonism Relat Disord. 2018 Dec;57:50-57. doi: 10.1016/j.parkreldis.2018.07.018. Epub 2018 Jul 27.

PMID:
30100364
12.

Identification of mutations in the PARK2 gene in Serbian patients with Parkinson's disease.

Jankovic MZ, Dobricic V, Kresojevic N, Markovic V, Petrovic I, Svetel M, Pekmezovic T, Novakovic I, Kostic V.

J Neurol Sci. 2018 Oct 15;393:27-30. doi: 10.1016/j.jns.2018.07.020. Epub 2018 Jul 24.

PMID:
30099245
13.

Investigation of metabolic properties and effects of 17β-carboxamide glucocorticoids on human peripheral blood leukocytes.

Dobričić V, Drvenica I, Stančić A, Mihailović M, Čudina O, Bugarski D, Ilić V.

Arch Pharm (Weinheim). 2018 May;351(5):e1700371. doi: 10.1002/ardp.201700371. Epub 2018 Apr 16.

PMID:
29660818
14.

WDR45 mutations may cause a MECP2 mutation-negative Rett syndrome phenotype.

Kulikovskaja L, Sarajlija A, Savic-Pavicevic D, Dobricic V, Klein C, Westenberger A.

Neurol Genet. 2018 Mar 27;4(2):e227. doi: 10.1212/NXG.0000000000000227. eCollection 2018 Apr. No abstract available.

15.

Design and Synthesis of Novel Deuterated Ligands Functionally Selective for the γ-Aminobutyric Acid Type A Receptor (GABAAR) α6 Subtype with Improved Metabolic Stability and Enhanced Bioavailability.

Knutson DE, Kodali R, Divović B, Treven M, Stephen MR, Zahn NM, Dobričić V, Huber AT, Meirelles MA, Verma RS, Wimmer L, Witzigmann C, Arnold LA, Chiou LC, Ernst M, Mihovilovic MD, Savić MM, Sieghart W, Cook JM.

J Med Chem. 2018 Mar 22;61(6):2422-2446. doi: 10.1021/acs.jmedchem.7b01664. Epub 2018 Mar 6.

PMID:
29481759
16.

Alkyl polyglucoside vs. ethoxylated surfactant-based microemulsions as vehicles for two poorly water-soluble drugs: physicochemical characterization and in vivo skin performance.

Pajić NZB, Todosijević MN, Vuleta GM, Cekić ND, Dobričić VD, Vučen SR, Čalija BR, Lukić MŽ, Ilić TM, Savić SD.

Acta Pharm. 2017 Dec 20;67(4):415-439. doi: 10.1515/acph-2017-0036.

PMID:
29337676
17.

Genomic variants in the FTO gene are associated with sporadic amyotrophic lateral sclerosis in Greek patients.

Mitropoulos K, Merkouri Papadima E, Xiromerisiou G, Balasopoulou A, Charalampidou K, Galani V, Zafeiri KV, Dardiotis E, Ralli S, Deretzi G, John A, Kydonopoulou K, Papadopoulou E, di Pardo A, Akcimen F, Loizedda A, Dobričić V, Novaković I, Kostić VS, Mizzi C, Peters BA, Basak N, Orrù S, Kiskinis E, Cooper DN, Gerou S, Drmanac R, Bartsakoulia M, Tsermpini EE, Hadjigeorgiou GM, Ali BR, Katsila T, Patrinos GP.

Hum Genomics. 2017 Dec 8;11(1):30. doi: 10.1186/s40246-017-0126-2.

18.

GCH1 mutations are common in Serbian patients with dystonia-parkinsonism: Challenging previously reported prevalence rates of DOPA-responsive dystonia.

Dobričić V, Tomić A, Branković V, Kresojević N, Janković M, Westenberger A, Rašić VM, Klein C, Novaković I, Svetel M, Kostić VS.

Parkinsonism Relat Disord. 2017 Dec;45:81-84. doi: 10.1016/j.parkreldis.2017.09.017. Epub 2017 Sep 18.

PMID:
28958832
19.

Evaluation of Biological Activity and Computer-Aided Design of New Soft Glucocorticoids.

Dobričić V, Jaćević V, Vučićević J, Nikolic K, Vladimirov S, Čudina O.

Arch Pharm (Weinheim). 2017 May;350(5). doi: 10.1002/ardp.201600383. Epub 2017 Apr 18.

PMID:
28418199
20.

Application of biopartitioning micellar chromatography and QSRR modeling for prediction of gastrointestinal absorption and design of novel β-hydroxy-β-arylalkanoic acids.

Dobričić V, Savić J, Nikolic K, Vladimirov S, Vujić Z, Brborić J.

Eur J Pharm Sci. 2017 Mar 30;100:280-284. doi: 10.1016/j.ejps.2017.01.023. Epub 2017 Jan 23.

PMID:
28126559
21.

Novel GNB1 mutations disrupt assembly and function of G protein heterotrimers and cause global developmental delay in humans.

Lohmann K, Masuho I, Patil DN, Baumann H, Hebert E, Steinrücke S, Trujillano D, Skamangas NK, Dobricic V, Hüning I, Gillessen-Kaesbach G, Westenberger A, Savic-Pavicevic D, Münchau A, Oprea G, Klein C, Rolfs A, Martemyanov KA.

Hum Mol Genet. 2017 Mar 15;26(6):1078-1086. doi: 10.1093/hmg/ddx018.

22.

In vitro prediction of gastrointestinal absorption of novel β-hydroxy-β-arylalkanoic acids using PAMPA technique.

Savić J, Dobričić V, Nikolic K, Vladimirov S, Dilber S, Brborić J.

Eur J Pharm Sci. 2017 Mar 30;100:36-41. doi: 10.1016/j.ejps.2017.01.005. Epub 2017 Jan 7.

PMID:
28077276
23.

A pilot study on predictors of brainstem raphe abnormality in patients with major depressive disorder.

Kostić M, Munjiza A, Pesic D, Peljto A, Novakovic I, Dobricic V, Tosevski DL, Mijajlovic M.

J Affect Disord. 2017 Feb;209:66-70. doi: 10.1016/j.jad.2016.11.034. Epub 2016 Nov 22.

PMID:
27888722
24.

Seemingly dominant inheritance of a recessive ANO10 mutation in romani families with cerebellar ataxia.

Mišković ND, Domingo A, Dobričić V, Max C, Braenne I, Petrović I, Grütz K, Pawlack H, Tournev I, Kalaydjieva L, Svetel M, Lohmann K, Kostić VS, Westenberger A.

Mov Disord. 2016 Dec;31(12):1929-1931. doi: 10.1002/mds.26816. Epub 2016 Oct 27. No abstract available.

PMID:
27787937
25.

Transcranial sonography in dopa-responsive dystonia.

Svetel M, Tomić A, Mijajlović M, Dobričić V, Novaković I, Pekmezović T, Brajković L, Kostić VS.

Eur J Neurol. 2017 Jan;24(1):161-166. doi: 10.1111/ene.13172. Epub 2016 Oct 12.

PMID:
27731537
26.

Five-year study of quality of life in myotonic dystrophy.

Peric S, Vujnic M, Dobricic V, Marjanovic A, Basta I, Novakovic I, Lavrnic D, Rakocevic-Stojanovic V.

Acta Neurol Scand. 2016 Nov;134(5):346-351. doi: 10.1111/ane.12549. Epub 2015 Dec 21.

PMID:
27696366
27.

Excellent outcome of pallidal deep brain stimulation in DYT6 dystonia: A case report.

Vuletic V, Chudy D, Almahariq F, Dobricic V, Kostic V, Bogdanovic N.

J Neurol Sci. 2016 Jul 15;366:18-19. doi: 10.1016/j.jns.2016.04.032. Epub 2016 Apr 19. No abstract available.

PMID:
27288769
28.

Multidimensional aspects of pain in myotonic dystrophies.

Peric M, Peric S, Rapajic N, Dobricic V, Savic-Pavicevic D, Nesic I, Radojicic S, Novakovic I, Lavrnic D, Rakocevic-Stojanovic V.

Acta Myol. 2015 Dec;34(2-3):126-32.

29.

HPCA-related dystonia: Too rare to be found?

Dobričić V, Kresojević N, Marjanović A, Tomić A, Svetel M, Novaković I, Kostić VS.

Mov Disord. 2016 Jul;31(7):1071. doi: 10.1002/mds.26634. Epub 2016 May 4. No abstract available.

PMID:
27145302
30.

Comparison of temporal and stride characteristics in myotonic dystrophies type 1 and 2 during dual-task walking.

Radovanović S, Perić S, Savić-Pavićević D, Dobričić V, Pešović J, Kostić V, Rakočević-Stojanović V.

Gait Posture. 2016 Feb;44:194-9. doi: 10.1016/j.gaitpost.2015.12.020. Epub 2015 Dec 20.

PMID:
27004657
31.

The cumulative effect of genetic polymorphisms on depression and brain structural integrity.

Kostic M, Canu E, Agosta F, Munjiza A, Novakovic I, Dobricic V, Maria Ferraro P, Miler Jerkovic V, Pekmezovic T, Lecic Tosevski D, Filippi M.

Hum Brain Mapp. 2016 Jun;37(6):2173-84. doi: 10.1002/hbm.23165. Epub 2016 Mar 9.

PMID:
26956059
32.

Subtelomeric screening in Serbian children with dysmorphic features and unexplained developmental delay/intellectual disabilities.

Damnjanovic T, Cuturilo G, Maksimovic N, Dimitrijevic N, Mitic V, Jekic B, Lukovic L, Bunjevacki V, Varljen T, Dobricic V, Jovanovic I, Kostic V, Novakovic I.

Turk J Pediatr. 2015 Mar-Apr;57(2):154-60.

PMID:
26690596
33.

Evaluation of critical formulation parameters in design and differentiation of self-microemulsifying drug delivery systems (SMEDDSs) for oral delivery of aciclovir.

Janković J, Djekic L, Dobričić V, Primorac M.

Int J Pharm. 2016 Jan 30;497(1-2):301-11. doi: 10.1016/j.ijpharm.2015.11.011. Epub 2015 Dec 1.

PMID:
26611669
34.

Modified local diatomite as potential functional drug carrier--A model study for diclofenac sodium.

Janićijević J, Krajišnik D, Čalija B, Vasiljević BN, Dobričić V, Daković A, Antonijević MD, Milić J.

Int J Pharm. 2015 Dec 30;496(2):466-74. doi: 10.1016/j.ijpharm.2015.10.047. Epub 2015 Oct 21.

PMID:
26498370
35.

Screening for C9orf72 Expansion Mutation in Serbian Patients with Early-Onset Dementia.

Mandic-Stojmenovic G, Stefanova E, Dobricic V, Novakovic I, Stojkovic T, Jesic A, Kostic V.

Dement Geriatr Cogn Disord. 2015;40(5-6):358-65. doi: 10.1159/000438748. Epub 2015 Sep 25.

PMID:
26401819
36.

Phenotype of non-c.907_909delGAG mutations in TOR1A: DYT1 dystonia revisited.

Dobričić V, Kresojević N, Žarković M, Tomić A, Marjanović A, Westenberger A, Cvetković D, Svetel M, Novaković I, Kostić VS.

Parkinsonism Relat Disord. 2015 Oct;21(10):1256-9. doi: 10.1016/j.parkreldis.2015.08.001. Epub 2015 Aug 10.

PMID:
26297380
37.

Influence of Solid Drug Delivery System Formulation on Poorly Water-Soluble Drug Dissolution and Permeability.

Krstić M, Popović M, Dobričić V, Ibrić S.

Molecules. 2015 Aug 13;20(8):14684-98. doi: 10.3390/molecules200814684.

38.

Are Leber's mitochondial DNA mutations associated with aquaporin-4 autoimmunity?

Dujmovic I, Jancic J, Dobricic V, Jankovic M, Novakovic I, Comabella M, Drulovic J.

Mult Scler. 2016 Mar;22(3):393-4. doi: 10.1177/1352458515590649. Epub 2015 Jul 24. No abstract available.

PMID:
26209590
39.

Variability of multisystemic features in myotonic dystrophy type 1--lessons from Serbian registry.

Rakocevic-Stojanovic V, Peric S, Basta I, Dobricic V, Ralic V, Kacar A, Peric M, Novakovic I.

Neurol Res. 2015 Nov;37(11):939-44. doi: 10.1179/1743132815Y.0000000068. Epub 2015 Jul 17.

PMID:
26184384
40.

Presenting symptoms of GBA-related Parkinson's disease.

Kresojević N, Janković M, Petrović I, Kumar KR, Dragašević N, Dobričić V, Novaković I, Svetel M, Klein C, Pekmezović T, Kostić VS.

Parkinsonism Relat Disord. 2015 Jul;21(7):804-7. doi: 10.1016/j.parkreldis.2015.04.028. Epub 2015 May 1.

PMID:
25957717
41.

Identification of novel variants in LRRK2 gene in patients with Parkinson's disease in Serbian population.

Janković MZ, Kresojević ND, Dobričić VS, Marković VV, Petrović IN, Novaković IV, Kostić VS.

J Neurol Sci. 2015;353(1-2):59-62. doi: 10.1016/j.jns.2015.04.002. Epub 2015 Apr 12.

PMID:
25899316
42.

Pattern of disease progression in atypical form of pantothenate-kinase-associated neurodegeneration (PKAN) - Prospective study.

Tomić A, Petrović I, Svetel M, Dobričić V, Dragašević Mišković N, Kostić VS.

Parkinsonism Relat Disord. 2015 May;21(5):521-4. doi: 10.1016/j.parkreldis.2015.02.006. Epub 2015 Feb 17.

PMID:
25724846
43.

Prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands using PAMPA technique and quantitative-structure permeability relationship analysis.

Vucicevic J, Nikolic K, Dobričić V, Agbaba D.

Eur J Pharm Sci. 2015 Feb 20;68:94-105. doi: 10.1016/j.ejps.2014.12.014. Epub 2014 Dec 24.

PMID:
25542610
44.

Metabolic syndrome in patients with myotonic dystrophy type 1.

Vujnic M, Peric S, Popovic S, Raseta N, Ralic V, Dobricic V, Novakovic I, Rakocevic-Stojanovic V.

Muscle Nerve. 2015 Aug;52(2):273-7. doi: 10.1002/mus.24540. Epub 2015 Jun 19.

PMID:
25487787
45.

Novel GNAL mutations in two German patients with sporadic dystonia.

Ziegan J, Wittstock M, Westenberger A, Dobričić V, Wolters A, Benecke R, Klein C, Kamm C.

Mov Disord. 2014 Dec;29(14):1833-4. doi: 10.1002/mds.26066. Epub 2014 Nov 7. No abstract available.

PMID:
25382112
46.

Frontostriatal dysexecutive syndrome: a core cognitive feature of myotonic dystrophy type 2.

Peric S, Mandic-Stojmenovic G, Stefanova E, Savic-Pavicevic D, Pesovic J, Ilic V, Dobricic V, Basta I, Lavrnic D, Rakocevic-Stojanovic V.

J Neurol. 2015 Jan;262(1):142-8. doi: 10.1007/s00415-014-7545-y. Epub 2014 Oct 28.

PMID:
25346064
47.

Mutations in Niemann Pick type C gene are risk factor for Alzheimer's disease.

Kresojević N, Dobričić V, Svetel M, Kostić V.

Med Hypotheses. 2014 Nov;83(5):559-62. doi: 10.1016/j.mehy.2014.08.025. Epub 2014 Sep 6.

PMID:
25220527
48.

Significant impact of behavioral and cognitive impairment on quality of life in patients with myotonic dystrophy type 1.

Rakocevic-Stojanovic V, Peric S, Madzarevic R, Dobricic V, Ralic V, Ilic V, Basta I, Nikolic A, Stefanova E.

Clin Neurol Neurosurg. 2014 Nov;126:76-81. doi: 10.1016/j.clineuro.2014.08.021. Epub 2014 Aug 30.

PMID:
25215445
49.

Design, synthesis, and local anti-inflammatory activity of 17β-carboxamide derivatives of glucocorticoids.

Dobričić V, Marković B, Milenković N, Savić V, Jaćević V, Rančić N, Vladimirov S, Cudina O.

Arch Pharm (Weinheim). 2014 Nov;347(11):786-97. doi: 10.1002/ardp.201400165. Epub 2014 Aug 27.

PMID:
25159891
50.

Shorter CTG repeats length in an oligodendroglioma from a myotonic dystrophy type 1 patient.

Rakocevic-Stojanovic V, Peric S, Ralic V, Milicevic M, Dobricic V.

Acta Neurol Belg. 2015 Sep;115(3):505-7. doi: 10.1007/s13760-014-0336-5. Epub 2014 Aug 6. No abstract available.

PMID:
25096749

Supplemental Content

Loading ...
Support Center